| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8769122 | Actas Urológicas Españolas | 2018 | 7 Pages |
Abstract
PCa in renal transplant patients can be managed with the same therapeutic options as in the general population. Active surveillance should also be provided in RTR despite being under immunosuppressive therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
A. Narváez, J. Suarez, L. Riera, M. Castells-Esteve, R. Cocera, F. Vigués,